384 related articles for article (PubMed ID: 27624381)
1. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
Jobski K; Höfer J; Hoffmann F; Bachmann C
Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
[TBL] [Abstract][Full Text] [Related]
5. Autism Spectrum Disorder: Classification, diagnosis and therapy.
Sharma SR; Gonda X; Tarazi FI
Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children.
Rasmussen L; Pratt N; Roughead E; Moffat A
J Autism Dev Disord; 2019 Jan; 49(1):227-235. PubMed ID: 30136113
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P
Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication use and polypharmacy in children with autism spectrum disorders.
Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A
Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704
[TBL] [Abstract][Full Text] [Related]
10. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
Rast JE; Anderson KA; Roux AM; Shattuck PT
Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
Madden JM; Lakoma MD; Lynch FL; Rusinak D; Owen-Smith AA; Coleman KJ; Quinn VP; Yau VM; Qian YX; Croen LA
J Autism Dev Disord; 2017 Jan; 47(1):144-154. PubMed ID: 27817163
[TBL] [Abstract][Full Text] [Related]
14. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
[TBL] [Abstract][Full Text] [Related]
15. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
[TBL] [Abstract][Full Text] [Related]
16. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review.
Yoshida K; Koyama E; Zai CC; Beitchman JH; Kennedy JL; Lunsky Y; Desarkar P; Müller DJ
Can J Psychiatry; 2021 Dec; 66(12):1019-1041. PubMed ID: 33222504
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.
Wink LK; Pedapati EV; Adams R; Erickson CA; Pedersen KA; Morrow EM; Kaplan D; Siegel M;
J Autism Dev Disord; 2018 Nov; 48(11):3711-3719. PubMed ID: 28516426
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
